or Try an Advanced Search...

    Respiratory Diseases Stocks List

    Symbol Grade Name % Change
    GILD F Gilead Sciences, Inc. -0.84
    WINT F Windtree Therapeutics, Inc. 14.09
    REVB F Revelation Biosciences, Inc. 0.85
    SMLR F Semler Scientific, Inc. 1.81
    VRNA D Verona Pharma plc -0.38
    EHAB D Enhabit, Inc. 1.90
    VMD D Viemed Healthcare, Inc. -0.12
    SVRA D Savara, Inc. 0.53
    TBPH C Theravance Biopharma, Inc. 0.96
    ALVO C Alvotech -0.76
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Care Facilities Medical Devices
    Related Stock Lists: Medicine Disease Cystic Fibrosis Biopharmaceutical Cardiovascular Disease Chronic Disease Diabetes Heart Disease Hypertension Infection Osteoporosis Pain Pharmaceutical Respiratory Therapy Therapy Services Vascular Disease Allergology Alzheimer's Disease Angina Antibiotics

    Related ETFs - A few ETFs which own one or more of the above listed Respiratory Diseases stocks.

    Symbol Grade Name Weight
    IBB C iShares Nasdaq Biotechnology Index Fund 8.14
    IBBQ C Invesco Nasdaq Biotechnology ETF 7.9
    BBH B Market Vectors Biotech ETF 7.81
    BIS D ProShares UltraShort Nasdaq Biotechnology 7.58
    BIB C ProShares Ultra Nasdaq Biotechnology 6.04
    View all Respiratory Diseases ETFs...
    Compare ETFs
    Compare BBH to BIB Compare IBB to BIB Compare IBBQ to BIB

        Respiratory Diseases Stocks Recent News

        Date Stock Title
        Feb 7 VMD (Exclusive) Stocks To Watch, PRO+ Edition
        May 3 GILD Forbes Has Listed Gilead as One of America’s Best Employers for Diversity
        May 3 GILD The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
        May 2 GILD Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
        May 2 ALVO Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
        May 2 VRNA Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024
        May 1 SMLR Semler Scientific: Not Perfect But Worth Considering
        Apr 30 GILD Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
        Apr 30 ALVO Alvotech to produce Humira biosimilar for Cigna's Quallent
        Apr 30 SMLR Semler Scientific, Inc. (NASDAQ:SMLR) is largely controlled by institutional shareholders who own 52% of the company
        Apr 30 ALVO U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
        Apr 29 GILD Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
        Apr 29 TBPH Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
        Apr 29 GILD Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
        Apr 27 GILD Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Care Facilities Medical Devices
        Related Stock Lists: Medicine Disease Cystic Fibrosis Biopharmaceutical Cardiovascular Disease Chronic Disease Diabetes Heart Disease Hypertension Infection Osteoporosis Pain Pharmaceutical Respiratory Therapy Therapy Services Vascular Disease Allergology Alzheimer's Disease Angina Antibiotics
        Respiratory Diseases

        Respiratory diseases are a group of conditions that affect the lungs and airways. These diseases can range from mild to severe and can include asthma, COPD, pneumonia, and lung cancer. Symptoms of respiratory diseases can include difficulty breathing, coughing, wheezing, and chest pain. Treatment for respiratory diseases can include medications, lifestyle changes, and surgery.

        Browse All Tags